The synthesis and anticonvulsant activity of some ω-phthalimido-N- phenylacetamide and propionamide derivatives

Archiv der Pharmazie

Volumn 337, Issue 2, 2004, Pages 105-111

  Soyer, Zeynep ^a   Kilic, Fatma Sultan ^b   Erol, Kevser ^b   Pabuccuoglu, Varol ^a  

^a EGE UNIVERSITY   (Turkey)

^b ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

2 Phthalimidoacetamide; 3 Phthalimidopropionamide; Anilide; Anticonvulsant; MES

Indexed keywords

PHTHALIMIDE DERIVATIVE; PROPIONAMIDE DERIVATIVE; ACETAMIDE DERIVATIVE; AMIDE; ANTICONVULSIVE AGENT; PROPIONAMIDE;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTRIC SHOCK; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEIZURE; SPECTROSCOPY; ANIMAL; CHEMISTRY; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ACETAMIDES; AMIDES; ANIMALS; ANTICONVULSANTS; MICE; SEIZURES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 1642316972     PISSN: 03656233     EISSN: None     Source Type: Journal    
DOI: 10.1002/ardp.200300823     Document Type: Article

References (25)

1. Z. Lin, P. K. Kadaba, Med. Res. Rev., 1997, 17, 537-572.
2. W. Löscher, Eur. J. Pharm., 1998, 342, 1-13.
3. R. J. Porter, Jpn.Psychiatr. Neur., 1993, 47, 145-162.
4. A. D. Fraser, Clin. Biochem., 1996, 29, 97-110.
5. B. H. Kohl and G. Dannhardt, Curr. Med. Chem., 2001, 8, 1275-1289.
6. S. Sussan, A. Dagan, S. Blotnik, M. Bialer, Epilepsy Res., 1999, 34, 207-220.
7. S. Hadad, M. Bialer, Pharmaceut. Res., 1995, 12, 905-910.
8. O. A. Salach, S. Hadad, A. Haj-Yehia, S. Sussan and M. Bialer, Pharmaceut. Res., 1994, 11, 1429-1434.
9. C. O. Usifoh, D. M. Lambert, J. Wouters, G. K. E. Scriba, Arch. Pharm. Pharm. Med. Chem., 2001, 334, 323-331.
10. C. R. Clark, Epilepsia, 1988, 29, 198-203.
11. I. E. Leppik, Epilepsia, 1994, 35, S29-S40.
12. V. Bailleux, L. Vallée, J. P. Nuyts, G. Hamoir, J. H. Poupaert, J. P. Stables and J. Vamecq, Epilepsia, 1995, 36, 559-565.
13. J. Vamecq, P. Bac, C. Herrenknecht, P. Maurois, P. Delcourt and J. P. Stables, J. Med. Chem., 2000, 43, 1311-1319.
14. V. Bailleux, L. Vallée, J. P. Nuyts, J. Vamecq, Biomed & Pharmacother., 1994, 48, 95-101.
15. V. Bailleux, L. Vallée, J. P. Nuyts and J. Vamecq, Chem. Pharm. Bull., 1994, 42, 1817-1821.
16. R. C. Clark, C. M. Lin and T. Sansom, J. Med. Chem., 1986, 29, 1534-1537.
17. A. Ghany, A. El-Helby, Egypt. J. Pharm. Sci., 1995, 36, 343-352.
18. C. B. Schapira, M. I. Abasolo and I. A. Perillo, J. Heterocylic. Chem., 1985, 22, 577-581.
19. M. M. H. Arief, A. F. Shaaban, S. A. Essawy and A. A. M. Khalil, Egypt. J. Chem., 1988, 31, 151-166.
20. H. Gnichtel and K. Hirte, Chem. Ber., 1975, 108, 3380-3386.
21. A. M. El-Naggar, I. M. Ismail and A. M. Gomaa, Egypt. J. Chem., 1978, 21, 309-313.
22. P. D. McMaster, E. W. Byrnes, H. S. Feldman, B. H. Takman, P. A. Tenthorey J. Med. Chem., 1979, 22, 1177-1182.
23. P. A. Tenthorey, R. L. D.Rubio, H. S. Feldman, B. H. Takman, J. Med. Chem., 1979, 22, 1182-1186.
24. F. E. D. Gangi, J. Am. Chem. Soc., 1955, XLIV, 135-137.
25. H. Uçar, K. V. Derpoorten, S. Cacciaguerra, S. Spampinato, J. P. Stables, P. Depovere, M. Isa, B. Masereel, J. Delarge and J. H. Poupaert, J. Med. Chem., 1998, 41, 1138-1145.